Oestrogen receptor β in breast cancer: Good, bad or still too early to tell?

Journal of Pathology

Volumn 197, Issue 2, 2002, Pages 143-147

  Speirs, Valerie ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Mammary gland; Oestrogen receptor

Indexed keywords

ANTIESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MESSENGER RNA; PROTEIN; TAMOXIFEN; TUMOR MARKER;

BREAST CANCER; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MOUSE; NONHUMAN; PATHOLOGY; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW;

BREAST NEOPLASMS; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; NEOPLASM PROTEINS; PROGNOSIS; RECEPTORS, ESTROGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0036262148     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1072     Document Type: Review

References (64)

1. Current status of estrogen receptors in human breast cancer
2. Hormone receptors: Their role in predicting prognosis and response to endocrine therapy
3. Hormonal chemoprevention of cancer in women
4. The nuclear receptor superfamily: The second decade
5. Cloning of a novel receptor expressed in rat prostate and ovary
6. Cloning, chromosomal localisation and functional analysis of the murine estrogen receptor β
7. ER-β: Identification and characterisation of a novel human estrogen receptor
8. The complete primary structure of human estrogen receptor β (hERβ) and its hetero-dimerisation with ERα in vivo and in vitro
9. A novel human estrogen receptor β: Identification and functional analysis of additional N-terminal amino acids
10. Cloning and characterisation of human estrogen receptor β isoforms
11. Human estrogen receptor β-gene structure, chromosomal localisation and expression pattern
12. Localisation of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique
13. Expression of estrogen receptor-β in human breast tumours
14. Co-expression of estrogen receptor-α and -β: Poor prognostic factors in human breast cancer?
15. Altered estrogen receptor α and β messenger RNA expression during human breast tumorigenesis
16. Estrogen receptor β messenger RNA expression in human breast tumor biopsies: Relationship to steroid receptor status and regulation by progestin
17. Expression of estrogen receptor β1, β2 and β5 messenger RNAs in human breast tissue
18. Expression and regulation of estrogen receptor β in human breast tumours and cell lines
19. A possible divergent role for the oestrogen receptor alpha and beta subtypes in clinical breast cancer
20. Quantitative analysis of estrogen receptor-α and -β messenger RNA expression in breast carcinoma by real-time polymerase chain reaction
21. Quantitative analysis of estrogen receptor-β mRNA and its variants in human breast cancers
22. Studies on oestrogen receptor-α and -β mRNA in human breast cancer
23. Messenger ribonucleic acid in situ hybridisation analysis of estrogen receptors α and β in human breast carcinoma
24. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β
25. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β
26. Human estrogen receptor β binds DNA in a manner similar to and dimerises with estrogen receptor α
27. Molecular cloning and characterisation of human estrogen receptor βcx: A potential inhibitor of estrogen action in human
28. Generation and reproductive phenotypes of mice lacking estrogen receptor β
29. Estrogen receptor null mice: What have we learned and where will they lead us?
30. Estrogen receptor β is co-expressed with ERα and PR and associated with nodal status, grade and proliferation in breast cancer
31. Increased expression of estrogen receptor β mRNA in tamoxifen resistant breast cancer patients
32. Alternative O-glycosylation/O-phosphorylation of the murine estrogen receptor β
33. Alternative O-glycosylation/O-phosphorylation of serine-16 murine estrogen receptor beta: Post-translational regulation turnover and transactivation activity
34. Expression of wild type estrogen receptor β and variant isoforms in human breast cancer
35. Human estrogen receptor beta-specific monoclonal antibodies: Characterisation and use in studies of estrogen receptor beta protein expression in reproductive tissues
36. Identification of wild type and exon 5 deletion variants of estrogen receptor β in normal human mammary gland
37. Expression of estrogen receptor β messenger RNA variant in breast cancer
38. Estrogen receptor-β mRNA variants in human and murine tissues
39. Clinical value of the wild-type estrogen receptor β expression in breast cancer
40. Immunohistochemical detection of ERβ in breast cancer: Towards more detailed receptor profiling?
41. Evaluation of seven oestrogen receptor β antibodies for immunohistochemistry, western blotting, and flow cytometry in human breast tissue
42. Estrogen receptor beta expression in invasive breast cancer
43. Estrogen receptors alpha and beta in the rodent mammary gland
44. Evaluation of androgen, estrogen (ERα and ERβ) and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays
45. Loss of estrogen receptor β expression in malignant human prostate cells in primary cultures and in prostate cancer tissues
46. Comparative studies of the estrogen receptors β and α and the androgen receptor in normal prostate glands, dysplasia and in primary and metastatic carcinoma
47. Differential expression of estrogen receptor-α and -β messenger RNAs as a potential marker of ovarian carcinogenesis
48. Absence of estrogen receptor β expression in metastatic ovarian cancer
49. Selective loss of estrogen receptor β in malignant colon
50. Expression of estrogen receptor (ER) subtypes and ERβ isoforms in colon cancer
51. Decreased expression of estrogen receptor β protein in proliferative preinvasive mammary tumours
52. Genetic changes in breast cancer detected by comparative genomic hybridisation
53. Comparative genomic hybridisation of fine needle aspirates from breast carcinomas
54. Deletion mapping of two potential chromosome 14 tumor suppressor loci in ovarian carcinoma
55. Frequent loss of hetero-zygosity on chromosome 14q occurs in advanced colorectal carcinoma
56. Estrogen receptor β acts as a dominant regulator of estrogen signalling
57. Immunolocalisation of oestrogen receptor beta in human tissues
58. The human myoepithelial cell is a natural tumour suppressor
59. Elucidation of a role for stromal steroid hormone receptors in mammary gland growth and development using tissue recombinants
60. Estrogen receptor interaction with co-activators and co-repressors
61. Transcription factor-specific requirements for coactivators and their acetyltransferase functions
62. Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells
63. Estrogen hits the surface
64. Cell membrane and nuclear estrogen receptors originate from a single transcript: Studies of ERα and ERβ expressed in Chinese hamster ovary cells